Serum Adropin Levels in Patients on Hemodialysis
Adropin is a novel pleotropic peptide involved in energy homeostasis, with possible contribution to cardiovascular protection through production of nitric oxide and subsequent blood pressure regulation. Given that patients undergoing hemodialysis (HD) are related with high cardiovascular risk, hyper...
Main Authors: | Dijana Boric-Skaro, Maja Mizdrak, Mirko Luketin, Dinko Martinovic, Daria Tokic, Marino Vilovic, Daniela Supe-Domic, Tina Ticinovic Kurir, Josko Bozic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/4/337 |
Similar Items
-
Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis
by: Mirko Luketin, et al.
Published: (2021-03-01) -
Role of Adropin in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target
by: Josko Bozic, et al.
Published: (2021-10-01) -
Serum Adropin Levels in Patients with Rheumatoid Arthritis
by: Petra Simac, et al.
Published: (2022-01-01) -
Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide
by: Tina Tičinović Kurir, et al.
Published: (2020-01-01) -
Association of Dialysis Malnutrition Score with Hypoglycemia and Quality of Life among Patients with Diabetes on Maintenance Hemodialysis
by: Melissa Claire Uy, et al.
Published: (2018-09-01)